Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Protection of IFNAR (-/-) mice against bluetongue virus serotype 8, by heterologous (DNA/rMVA) and homologous (rMVA/rMVA) vaccination, expressing outer-capsid protein VP2.
Jabbar TK, Calvo-Pinilla E, Mateos F, Gubbins S, Bin-Tarif A, Bachanek-Bankowska K, Alpar O, Ortego J, Takamatsu HH, Mertens PP, Castillo-Olivares J. Jabbar TK, et al. PLoS One. 2013 Apr 12;8(4):e60574. doi: 10.1371/journal.pone.0060574. Print 2013. PLoS One. 2013. PMID: 23593251 Free PMC article.
Recombinant vaccines against bluetongue virus.
Calvo-Pinilla E, Castillo-Olivares J, Jabbar T, Ortego J, de la Poza F, Marín-López A. Calvo-Pinilla E, et al. Virus Res. 2014 Mar;182:78-86. doi: 10.1016/j.virusres.2013.11.013. Epub 2013 Nov 25. Virus Res. 2014. PMID: 24287057 Free article. Review.
Vaccination of mice with a modified Vaccinia Ankara (MVA) virus expressing the African horse sickness virus (AHSV) capsid protein VP2 induces virus neutralising antibodies that confer protection against AHSV upon passive immunisation.
Calvo-Pinilla E, de la Poza F, Gubbins S, Mertens PP, Ortego J, Castillo-Olivares J. Calvo-Pinilla E, et al. Virus Res. 2014 Feb 13;180:23-30. doi: 10.1016/j.virusres.2013.12.002. Epub 2013 Dec 12. Virus Res. 2014. PMID: 24333835 Free article.
Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge.
Alberca B, Bachanek-Bankowska K, Cabana M, Calvo-Pinilla E, Viaplana E, Frost L, Gubbins S, Urniza A, Mertens P, Castillo-Olivares J. Alberca B, et al. Vaccine. 2014 Jun 17;32(29):3670-4. doi: 10.1016/j.vaccine.2014.04.036. Epub 2014 May 14. Vaccine. 2014. PMID: 24837765 Free PMC article.
202 results